Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
Department of Anesthesia, Kyoto University Hospital, Kyoto, Japan.
Acta Anaesthesiol Scand. 2020 Aug;64(7):928-935. doi: 10.1111/aas.13584. Epub 2020 Apr 14.
Perioperative goal-directed fluid therapy is used for haemodynamic optimization in high-risk surgeries. Cardiac output monitoring can be performed by a specialized pressure transducer for arterial pulse waveform analysis (S-APWA). No study has assessed whether real-world use of S-APWA is associated with post-operative outcomes; therefore, using a Japanese administrative claims database, we retrospectively investigated whether S-APWA use is associated with in-hospital mortality among patients undergoing high-risk surgery under general anaesthesia.
Adult patients who underwent high-risk surgery under general anaesthesia and arterial catheterization between 2014 and 2016 were divided into S-APWA and conventional arterial pressure transducer groups, then compared regarding baseline factors and outcomes. Logistic regression analysis was performed to compare in-hospital mortality. Subgroup analyses evaluated S-APWA efficacy and outcomes based on the type of surgery and patients' comorbidity.
S-APWA was used in 6859 of 23 655 (29.0%) patients; the crude in-hospital mortality rate was 3.5%. Adjusted analysis showed no significant association between S-APWA use and in-hospital mortality rate (adjusted odds ratio [aOR] = 0.91; 95% confidence interval [CI]: 0.76-1.07; P = .25). S-APWA use was associated with significantly lower in-hospital mortality in patients undergoing vascular surgery (aOR = 0.67; 95% CI: 0.49-0.94), and significantly higher in-hospital mortality in patients undergoing lower limb amputation (aOR = 2.63; 95% CI: 1.32-5.22). S-APWA use and in-hospital mortality were not significantly associated with other subgroups.
S-APWA use was not associated with in-hospital mortality in the entire study population. However, S-APWA was associated with decreased in-hospital mortality among vascular surgery and increased in-hospital mortality among lower limb amputation.
围手术期目标导向液体治疗用于高危手术中的血流动力学优化。心输出量监测可通过专门的压力传感器进行动脉脉搏波形分析(S-APWA)。尚无研究评估现实中使用 S-APWA 是否与术后结果相关;因此,我们使用日本行政索赔数据库,回顾性调查了全身麻醉下接受高危手术的患者中使用 S-APWA 是否与住院死亡率相关。
将 2014 年至 2016 年间全身麻醉下接受高危手术和动脉置管的成年患者分为 S-APWA 和常规动脉压力传感器组,然后比较基线因素和结果。采用 logistic 回归分析比较住院死亡率。亚组分析根据手术类型和患者合并症评估 S-APWA 的疗效和结果。
23655 例患者中有 6859 例(29.0%)使用了 S-APWA;住院死亡率为 3.5%。校正分析显示,S-APWA 使用与住院死亡率之间无显著关联(校正比值比[aOR] = 0.91;95%置信区间[CI]:0.76-1.07;P =.25)。S-APWA 用于血管手术患者时,住院死亡率显著降低(aOR = 0.67;95%CI:0.49-0.94),用于下肢截肢患者时,住院死亡率显著升高(aOR = 2.63;95%CI:1.32-5.22)。S-APWA 应用与其他亚组之间的住院死亡率无显著相关性。
S-APWA 的使用与整个研究人群的住院死亡率无关。然而,S-APWA 与血管手术的住院死亡率降低有关,与下肢截肢的住院死亡率升高有关。